The Rules Committee of the House of Representatives of the United States of America (USA), held this Wednesday a hearing on the Cannabis Opportunity Reinvestment and Purge Act (the “MORE Act”), which decriminalizes cannabis at the federal level. The measure should go to the plenary today for a vote. More than two-thirds of Americans support repealing the federal cannabis ban.
The cannabis sector is in an uproar and markets are showing signs of optimism regarding the vote to up the Cannabis Opportunity, Reinvestment and Purge Act (MORE Act). The MORE Act, or HR 3617, removes cannabis from the Controlled Substances legal regime, facilitates amnesty for convicts, promotes diversified participation in the regulated cannabis industry, and helps repair the racially and economically disparate harms caused by the disastrous ban on cannabis. prohibitionist policies. The measure has been admitted for a vote in the House of Representatives, but it does not yet appear to be formally scheduled. There are Democrats who believe that this legislation is unlikely to be passed by the Senate.
Second vote for the legalization of cannabis
In 2020, the MORE bill was voted on in the House of Representatives, but it did not pass the Senate. That's why, this time around, the industry is convinced that the outcome of the vote could actually be the tipping point of the cannabis ban. If the act is approved in the House of Representatives, then it will be up to the Senate to carry out the vote that could bring this measure into force.
American companies are confident that this measure will be approved and that it could also be approved by the Senate. If that happens, it will end criminal penalties for those selling cannabis in states where that activity is already legal, and it will decriminalize cannabis use across the US, formally allowing states to enforce their own regulations and set the mold for commercial cannabis sales. .
"Advancing this legislation to declassify cannabis and helping those individuals and communities who have been impacted by America's failed ban is critical," said NORML Political Director Morgan Fox. “More than two-thirds of Americans support repealing the federal cannabis ban and deserve to know where our elected officials stand on this issue.
“On behalf of cannabis users across the country and the people who have been victimized and marginalized as a result of our misguided federal cannabis laws, we thank House Speaker Pelosi and Majority Leader Hoyer, the President of the Judiciary of House, Jerry Nadler, Representatives Earl Blumenauer, Jim Clyburn, Hakeem Jeffries, Barbara Lee, Sheila Jackson Lee, Ed Perlmutter, Nydia Velasquez and many others for their strong support for comprehensive cannabis policy reform and their efforts to bring this legislation the vote.”
What does the MORE Act propose?
This bill decriminalizes cannabis and specifically removes it from the list of controlled substances under the Controlled Substances Act, eliminating criminal penalties for the individual who manufactures, distributes or possesses cannabis. The bill also makes other changes, including the following:
- replaces legal references to “marijuana” and “marihuana” with “cannabis”;
- requires the Bureau of Labor Statistics to regularly publish demographic data on cannabis business owners and employees;
- establishes a trust fund to support various programs and services for individuals and businesses in drug war-affected communities;
- imposes a special tax on cannabis products produced in or imported into the United States and an occupational tax on cannabis production facilities and export warehouses;
- provides loans and small business administration services to entities that are legitimate cannabis-related businesses or service providers;
- prohibits the denial of federal public benefits to a person based on certain cannabis-related conduct or beliefs;
- prohibits denial of benefits and protections under immigration laws based on a cannabis-related event (eg, conduct or conviction)
- establishes a process for expunging convictions and conducting sentencing review hearings related to federal cannabis crimes, directing the Government Accountability Office to study the social impact of cannabis legalization.
Porto, Matosinhos, Valongo and Paredes – Eight arrested for drug trafficking and more than 8000 doses of drugs seized
The Porto Territorial Command, through the Criminal Investigation Center (NIC) of Santo Tirso, between the 20th and...
Portugal: GNR seizes 3 tons of hashish in the Guadiana River
The Coastal and Border Control Unit (UCCF) of the National Republican Guard (GNR) seized last Friday, the 23rd...
Spannabis 2024: Barcelona hosts the 20th edition of the largest cannabis exhibition in the world, from March 15th to 17th
Barcelona is preparing to host the 20th edition of Spannabis, the largest cannabis fair in the world, on the 15th,...
Germany: Bundestag voted today in favor of legalizing cannabis, but Federal Council approval is still needed
The Bundestag debated and voted this afternoon on the project to legalize the personal use of cannabis in the country, with 407...
Germany: Legalization will be discussed this Friday, the 23rd
The German Bundestag will finally deliberate on the legalization of cannabis for personal consumption in the country. The debate, which has been...
Hemp cultivation in the Azores will have an information session on Terceira Island
The Confraria Internacional Cannabis Portugal and CannAzores join forces to promote an Information Session on the Cultivation of...
CBD and CBC show promising results in head and neck squamous cell carcinoma
A study published in the journal Cancers found that cannabis extracts rich in CBD (cannabidiol) can kill breast cancer cells...
Ukraine: Zelensky signs bill to legalize medical cannabis
Ukrainian President Volodymyr Zelensky signed a bill legalizing medical cannabis in Ukraine, with the expectation that...
Portugal: Associação Mães pela Canábis publishes e-book on medicinal cannabis
The Association of Mothers for Cannabis (AMC) announced the launch of an e-book entitled “Frontiers of Cannabis: SCIENCE, THERAPEUTICS &...
Akanda signs letter of intent to sell RPK Biopharma to Somaí. “It will be one of the few vertical cannabis companies in the EU”, says Michael Sassano
Akanda Corporation, an international medical cannabis company listed on Nasdaq (AKAN) and which owns the Portuguese company Holigen, announced...